5. Employees
5.1 Equity compensation benefit
 

During the year, 8 717 136 (2021: 14 611 406) forfeitable shares were granted to Executive Directors and qualifying employees (participant). The participant will forfeit the forfeitable shares if he/she ceases to be an employee of an employer company before the vesting date or if the specified performance conditions have not been met, unless otherwise specified by the rules or determined by the Board. In the event that the participant is not in the employ of the Group, or the performance conditions are not met, the shares allocated to the participant will be forfeited and will either be sold on the open market by the escrow agent and the proceeds will be returned to the participating employer, or may be retained by the Group for future awards.

Dividends declared in respect of these forfeitable shares are held in escrow until such time as the performance conditions are met and the shares have vested. Shares forfeited during the vesting period will forfeit any dividends pertaining to such shares. No dividend was declared during the current or prior year.

The performance condition for Executive Directors/senior managers respectively for the eleventh award grant that vested on 16 March 2022 are as follows:

  • 33.33%/40% for retention (three years from date of award); and
  • 66.67%/60% financial (33.34%/30% for growth in core headline earnings per share and 33.33%/30% based on shareholder returns).

The 33.34%/30% for growth in core headline earnings per share is based on the following achievements:

  • if growth is 5% above CPI compounded annually over three years, then 20% of the 33.34%/30% will vest;
  • if growth is 10% above CPI compounded annually over three years, then an additional 50% (i.e. a total of 70%) of the 33.34%/30% would vest. If growth is between 5% and 10% above CPI over the three years, then the additional 50% will be reduced on a pro rata basis; and
  • if growth is 25% above CPI compounded annually over three years, then a further 30% (i.e. a total of 100%) of the 33.34%/30% will vest. If growth is between 10% and 25% above CPI over the three years, then the additional 30% will be reduced on a pro rata basis.

The 33.33%/30% for shareholder return is based on a 10% compounded growth in the share price over the three-year vesting period, measured with reference to the weighted average price per share during the month of the commencement of the allocation plus dividends over the three-year period against the weighted average share price for the month during which the vesting takes place.

The performance criteria for senior managers will be measured at subsidiary level.

The performance conditions for the twelfth, thirteenth and fourteenth award grant vesting on 31 August 2022, 31 August 2023 and 31 August 2024 respectively are as follows:

  Group long-term incentive (LTI) metrics*
Threshold Target Stretch

Core HEPS (30%)
(compounded cumulatively over three years)

Group

CPI + 5%

CPI + 10%

CPI + 15%

Vesting %

21.6%

30.0%

42.0%

Total shareholder return (TSR) (30%)
(performance against JSE Capped All Share Index)

Group

Greater than or equal to JSE Capped

JSE Capped All Share Index

JSE Capped All Share Index

 

All Share Index

Return + CPI +5%
(average not compounded over three years)

Return + CPI +15%
(average not compounded over three years)

 

Vesting %

21.6%

30.0%

42.0%

Return on capital employed (ROCE)** (20%)
(compared to weighted average cost of capital (WACC) over the three-year period not compounded)

Group

ROCE greater than or equal to WACC over three years

ROCE greater than or equal to
WACC +2.5% over three years

ROCE greater than or equal to
WACC +5% over three years

Vesting %

14.4%

20.0%

28.0%

Environmental, social and governance (ESG) (20%) (specific ESG metrics)

Group

Specific ESGs selected

Specific ESGs selected

Specific ESGs selected

Vesting %

14.4%

20.0%

28.0%

* Remco may review metrics and targets post-FY2022 for new awards to ensure that they are relevant. The LTI is calculated per objective. Values awarded will be a weighted average of scores attained versus target and pro-rated as the case may be.
** ROCE is calculated using the following formula:
  ROCE = Net operating profit (EBIT)/Capital employed. Capital employed = total assets – current liabilities (excluding interest-bearing borrowings).
  The Remuneration Committee will review any prior year impairments to assess if adverse outcomes have occurred, and if so, make the necessary adjustments to the capital employed number such that the average performance is a more accurate indication to shareholders over the measurement period.

Critical accounting estimates and assumptions

In determining the number of forfeitable shares that will vest due to performance conditions being met, management assesses the attrition rates of staff based on the grades of staff that have been granted awards as well as the historic staff turnover.

Movements in the number of forfeitable shares outstanding during the year are as follows:

  Grant date Vesting date Number
of shares
Fair value
of grant
R’000
At 31 May 2020     23 370 753 101 911
10th award     1 401 656 25 917
11th award     4 332 402 31 020
12th award     17 636 695 44 974
Granted during the year     14 611 406 46 756
13th award 1 September 2020 31 August 2023 14 611 406 46 756
Shares forfeited during the year     (2 517 085) (20 201)
10th award     (755 449) (13 968)
11th award     (377 593) (2 704)
12th award     (1 384 043) (3 529)
Shares vested during the year     (1 174 045) (13 774)
10th award   31 August 2020 (646 207) (11 949)
11th award   31 August 2020 (36 541) (262)
11th award   31 March 2021 (46 417) (332)
12th award   31 August 2020 (108 758) (277)
12th award   31 March 2021 (187 059) (477)
13th award   31 March 2021 (149 063) (477)
At 31 May 2021     34 291 029 114 692
11th award     3 871 851 27 722
12th award     15 956 835 40 691
13th award     14 462 343 46 279
Granted during the year     8 717 136 55 964
14th award 6 April 2022 31 August 2024 8 717 136 55 964
Shares forfeited during the year     (5 245 249) (25 594)
11th award     (2 419 789) (17 326)
12th award     (1 190 058) (3 035)
13th award     (1 635 402) (5 233)
Shares vested during the year     (1 452 062) (10 396)
11th award   16 March 2022 (1 452 062) (10 396)
At 31 May 2022     36 310 854 134 666
12th award     14 766 777 37 656
13th award     12 826 941 41 046
14th award     8 717 136 55 964

Refer to note 5.2 for the expense recognised in the income statement relating to the equity compensation benefits.

The fair value of the shares is based on the open market closing price at grant date.

The total number of forfeitable shares issued to Executive Directors during the period is 2 032 567 (2021: 3 847 014).

The share-based payment expense in relation to these Executive Directors is R11.2 million (2021: R6.9 million). Refer to note 5.3 for details of awards per Director.